Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000875275 | SCV000723501 | benign | not provided | 2019-08-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000875275 | SCV001017574 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000612664 | SCV001362581 | benign | not specified | 2019-11-16 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813524 | SCV002060535 | likely benign | Noonan syndrome and Noonan-related syndrome | 2020-06-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420629 | SCV002728378 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2019-02-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000875275 | SCV004152229 | benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | LZTR1: BP4, BP7, BS1, BS2 |